Searched for
PFIZER BIONTECH MRNA COVID 19 VACCINE
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...- GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Could cancer vaccines become a reality? Here’s what experts sayA cancer vaccine could be a reality in a few years, according to the co-founders of BioNTech, a German company, which also manufactured the...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
- EU plans to boost reach of Pfizer COVID-19 shotThe European Medicines Agency said it would review data, including results from an ongoing study, for the vaccine - known as Comirnaty. It ...
- BioNTech shot produces 10x more antibodies than Sinovac: StudyThe research, published in The Lancet, found that antibody levels among Hong Kong health workers who have been fully vaccinated with BioNTe...
- Discussions underway with GOI for supply of Pfizer-BioNTech COVID vaccine, says PfizerIn a statement on Monday, Pfizer spokesperson said: "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-B...
- Not in talks with local companies to make vaccine in India: PfizerVarious governments, WHO and others have been pushing vaccine makers to transfer technology to companies in Asia and Africa to scale up pro...
- Vaccine maker BioNTech says no need to waive patentsUgur Sahin, the chief executive of BioNTech, rejected the U.S.-backed proposal to temporarily lift some intellectual property rights for va...
- BioNTech committed to deliver 1.8 billion doses of COVID-19 vaccine this yearBioNTech's first-quarter total revenues were 2.05 billion euros, up from 27.7 million a year earlier, inflated by the vaccine, and includin...
- EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022: EU sourceThe EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...
- Pfizer to develop new vaccines on its own using mRNA technologyThe drugmaker said it was ready to pursue mRNA on its own following its experience in the past year working on the COVID-19 vaccine, the WS...
- Pfizer sees $15 billion in 2021 sales from COVID-19 vaccinePfizer said it had supplied 65 million doses globally and 29 million doses in the United States as of Jan. 31. It expects to supply 200 mil...
- Pfizer-BioNTech say Covid vaccine works against UK, South Africa variantsWhile the findings indicated no need for a new vaccine to tackle the new strains, Pfizer and BioNTech said they would respond if there was ...
- Norway probes 23 elderly patients' death after Pfizer vaccinationDoctors in Norway have been asked to conduct more thorough evaluations of very frail elderly patients in line to receive the Pfizer-BioNTec...
- The understated husband-and-wife 'dream team' behind Pfizer's coronavirus vaccinePfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The compan...
- Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large s...
- GSK collaborates with Germany's CureVac, set to take 10% stake for $163 millionBritain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...
Load More
